RE-BVS – Piemonte Repository

Sfoglia per AUTORE
HEGE K
Collezione AOU Città della Salute di Torino

Items : 3

Avadomide plus obinutuzumab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (CC-122-NHL-001): a multicentre, dose escalation and expansion phase 1 study. in The Lancet. Haematology / Lancet Haematol. 2020 Sep;7(9):e649-e659. doi: 10.1016/S2352-3026(20)30208-8. Epub 2020 Aug 3.

2020
AOU Città della Salute di Torino

Michot JM; Bouabdallah R; Vitolo U; Doorduijn JK; Salles G; Chiappella A; Zinzani PL; Bijou F; Kersten MJ; Sarmiento R; Mosulen S; Mendez C; Uttamsingh S; Pourdehnad M; Hege K; Chen T; Klein C; Hagner PR; Nikolova Z; Ribrag V;

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. in The Lancet. Haematology / Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5.

2020
AOU Città della Salute di Torino

Young G; Gauger CA; Massicotte MP; Kállay K; Peters M; Saracco P; Martinelli I; Biss TT; Beyer-Westendorf J; Lvova O; Yee DL; Bhat RV; Chalmers E; Simioni P; Amedro P; Santamaría A; Holzhauer S; Kenet G; Chan AKC; Hooimeijer HL; Torres M; Connor P; Bonnet D; Hege K; Nurmeev I; Kumar R; Palumbo JS; Male C; Lensing AWA; et alii...

Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT). in Blood advances / Blood Adv. 2020 Dec 22;4(24):6250-6258. doi: 10.1182/bloodadvances.2020003244.

2020
AOU Città della Salute di Torino

Connor P; Sánchez van Kammen M; Lensing AWA; Chalmers E; Kállay K; Hege K; Simioni P; Biss T; Bajolle F; Bonnet D; Grunt S; Kumar R; Lvova O; Bhat R; Van Damme A; Palumbo J; Santamaria A; Saracco P; Payne J; Baird S; Godder K; Labarque V; Male C; Martinelli I; Morales Soto M; Motwani J; Shah S; Hooimeijer HL; Prins MH; et alii...